ProMIS Neurosciences (PMN) Stock Chart & Stock Price History $0.52 +0.01 (+2.81%) As of 05/23/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ProMIS Neurosciences Stock Price Performance The ProMIS Neurosciences (PMN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 71.06%, with a year-to-date return of -46.72%. In the past month, the stock has decreased 9.98%, reflecting recent market activity. As of the latest close, ProMIS Neurosciences traded at $0.51 with a market cap of $16.51 million and volume of 13,840 shares. Receive PMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.00%1 Month Performance-9.98%3 Month Performance-36.89%Year-To-Date Performance-46.72%1 Year Performance-71.06% PMN Stock Chart for Saturday, May, 24, 2025 PMN Chart by TradingView ProMIS Neurosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/23/2025$0.51$0.51-1.75%$0.54$0.4913,840 shs$16.51 million05/22/2025$0.51$0.51+0.19%$0.54$0.5013,475 shs$16.80 million05/21/2025$0.53$0.51-2.29%$0.54$0.4917,560 shs$16.77 million05/20/2025$0.50$0.53+5.00%$0.55$0.4919,602 shs$17.16 million05/19/2025$0.50$0.50$0.52$0.4933,172 shs$16.34 million05/16/2025$0.53$0.50-5.66%$0.55$0.4838,546 shs$16.34 million05/15/2025$0.51$0.53+4.95%$0.54$0.5014,848 shs$17.33 million05/14/2025$0.52$0.51-2.88%$0.55$0.5037,472 shs$16.51 million05/13/2025$0.50$0.52+3.79%$0.58$0.4896,074 shs$17.00 million05/12/2025$0.50$0.50+0.95%$0.59$0.50227,297 shs$16.38 million Get the Latest News and Ratings for PMN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 05/09/2025$0.50$0.50-0.74%$0.51$0.4944,777 shs$16.22 million05/08/2025$0.56$0.50-10.63%$0.60$0.47150,829 shs$16.34 million05/07/2025$0.58$0.56-2.70%$0.59$0.5547,729 shs$18.29 million05/06/2025$0.64$0.58-10.16%$0.70$0.5881,551 shs$18.80 million05/05/2025$0.64$0.64$0.72$0.6339,195 shs$20.92 million05/02/2025$0.65$0.64-1.54%$0.67$0.5917,982 shs$20.92 million05/01/2025$0.62$0.65+4.86%$0.65$0.6115,218 shs$21.25 million04/30/2025$0.58$0.62+6.33%$0.62$0.5812,723 shs$20.26 million04/29/2025$0.60$0.58-3.33%$0.62$0.5625,006 shs$19.06 million04/28/2025$0.59$0.60+2.50%$0.62$0.5648,671 shs$19.72 million04/25/2025$0.56$0.59+4.88%$0.60$0.5620,920 shs$19.23 million04/24/2025$0.59$0.56-5.68%$0.63$0.567,442 shs$18.34 million04/23/2025$0.61$0.59-2.30%$0.63$0.5630,412 shs$19.44 million Related Companies ZIVO Bioscience Stock Price Chart TScan Therapeutics Stock Price Chart Telomir Pharmaceuticals Stock Price Chart Clearside Biomedical Stock Price Chart IO Biotech Stock Price Chart BeyondSpring Stock Price Chart MediciNova Stock Price Chart vTv Therapeutics Stock Price Chart Assertio Stock Price Chart Conduit Pharmaceuticals Stock Price Chart Receive PMN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PMN) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ProMIS Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.